/
/
/

Shukra Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Open (₹)56.35
Volume (₹)2.82 L
High (₹)57.34
Upper Circuit68.31
Low (₹)55.11
Lower Circuit45.55
Prev Close56.93
52W High (₹)65.26
Price55.73
52W Low (₹)26.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)2509.40 Cr
Div. Yield (%)0.02
PE Ratio69.61
Debt to Equity0.06
Price to Book15.73
Book Value1.93
EPS (TTM)0.82
Face Value1.00
ROE (%)29.94

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
SHUKRAPHAR-BNSE
LTP
1W Low
1W High
Market cap (₹)
1853+17.5 (0.95%)
1835.50
1890.40
4,47,476Cr
9613+246 (2.63%)
9305.95
9739.85
2,54,764Cr
4935+130.75 (2.72%)
4864.80
5010
1,89,423Cr
1180+27 (2.34%)
1152
1191
1,16,658Cr
1404+32.55 (2.37%)
1364
1418.70
1,11,484Cr
2026.25+71 (3.63%)
1964.50
2054.55
1,09,943Cr
2475+157 (6.77%)
2302.30
2503.20
1,01,712Cr
1200.4+29.3 (2.50%)
1186.20
1221.60
1,01,005Cr
1720-15 (-0.86%)
1690
1739.60
99,253Cr
2098-46.7 (-2.18%)
2084.50
2129.85
96,031Cr
55.73-0.23 (-0.41%)
54.97
59.76
2,509Cr

Key Highlights of Shukra Pharmaceuticals Ltd’s P&L

In 2025-03-31, Shukra Pharmaceuticals Ltd reported total revenue of ₹32.59Cr, compared with ₹74.57Cr in 2024-03-31, reflecting Shukra Pharmaceuticals Ltd turnover.

Depreciation was ₹3Cr and finance costs were ₹59.49Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹13.34Cr in 2025-03-31 as compared to ₹19.88Cr in 2024-03-31.

Net Profit (PAT) was ₹9.58Cr in 2025-03-31 compared with ₹18.54Cr in 2024-03-31.

Earnings per share (EPS) were ₹0.22 in 2025-03-31, compared with ₹16.94 in 2024-03-31.